Rare Cancers
FY22 Idea Development Award
The list of Fiscal Year 2022 Rare Cancers Research Program Idea Development Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Beckman Research Institute of City of Hope | Marcin Kortylewski |
BloodCenter of Wisconsin | Nan Zhu |
Boston Medical Center | Christopher Heaphy |
H. Lee Moffitt Cancer Center and Research Institute | Pei-Ling Chen |
Icahn School of Medicine at Mount Sinai | Daniela Sia |
MD Anderson Cancer Center | Jo Ishizawa |
MD Anderson Cancer Center | Joseph Ludwig |
MD Anderson Cancer Center | Marie-Claude Hofmann |
MD Anderson Cancer Center | Venkata Lokesh Battula |
Memorial Sloan Kettering Cancer Center | Luc Morris |
New York Institute of Technology, Inc. | Haotian Zhao |
Oregon Health and Science University | Sanjay Malhotra |
The Leland Stanford Junior University | Electron Kebebew |
The Ohio State University | Steven Sizemore |
University of California San Diego | Andrew Lowy |
University of California, Los Angeles | Anthony Wang |
University of Chicago | Huanhuan Chen |
University of Michigan | Ryan Wilcox |
University of Minnesota Twin Cities | Jianfang Ning |
University of New South Wales | Tao Liu |
University of Notre Dame | Xin Lu |
Virginia Commonwealth University | Anthony Faber |
Last updated Tuesday, April 11, 2023